As reported by Interfax, a day earlier the country took such measures, but only with respect to residents over 60 years old. The Dutch doctors took such a step, having received new data on the formation of blood clots in some patients after being vaccinated with this drug.
On the eve the Agency for the Regulation of Medicines and Medical Devices of the UK said that identified 30 cases of thrombosis in patients after vaccination with the AstraZeneca vaccine.
Earlier it was reported that some countries temporarily suspended the use of the AstraZeneca vaccine due to reports of side effects, but some of them resumed its use against the background of an increase in the number of infections and a lack of vaccines.
It is still not clear if they are just a coincidence or a genuine side effect of the vaccine.
The Medicines and Healthcare Products Regulatory Agency says the benefits continue to outweigh any risk.
The World Health Organization and the European Medicines Agency have echoed this conclusion.
A spokeswoman for AstraZeneca said: "Patient safety remains the company's highest priority."